Adherence to guidelines for the prescription of secondary prevention medication at hospital discharge after acute coronary syndrome: a multicentre study

[1] Fox KA(2007)Decline in rates of death and heart failure in acute coronary syndromes, 1999–2006 JAMA 297 1892-900

[2] Steg PG(2004)A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry JAMA 291 2727-33

[3] Eagle KA(2008)Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the task force on the management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J 29 2909-45

[4] Eagle KA(2011)ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J 32 2999-3054

[5] Lim MJ(2010)Guideline-recommended secondary prevention drug therapy after acute myocardial infarction: predictors and outcomes of nonadherence Eur J Cardiovasc Prev Rehabil 17 576-81

[6] Dabbous OH(2013)Use and effects of cardiac rehabilitation in patients with coronary heart disease: results from the EUROASPIRE III survey Eur J Prev Cardiol 20 817-26

[7] Van de Werf F(2009)Potential survival gains in the treatment of myocardial infarction Heart 95 1844-50

[8] Bax J(2006)Association between hospital process performance and outcomes among patients with acute coronary syndromes JAMA 295 1912-20

[9] Betriu A(2011)Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction JAMA 305 1677-84

[10] Hamm CW(2014)Monitoring guideline adherence in the management of acute coronary syndrome in hospitals: design of a multicentre study Neth Heart J 22 346-53

[1] Fox KA(2007)Decline in rates of death and heart failure in acute coronary syndromes, 1999–2006 JAMA 297 1892-900

[2] Steg PG(2004)A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry JAMA 291 2727-33

[3] Eagle KA(2008)Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the task force on the management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J 29 2909-45

[4] Eagle KA(2011)ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J 32 2999-3054

[5] Lim MJ(2010)Guideline-recommended secondary prevention drug therapy after acute myocardial infarction: predictors and outcomes of nonadherence Eur J Cardiovasc Prev Rehabil 17 576-81

[6] Dabbous OH(2013)Use and effects of cardiac rehabilitation in patients with coronary heart disease: results from the EUROASPIRE III survey Eur J Prev Cardiol 20 817-26

[7] Van de Werf F(2009)Potential survival gains in the treatment of myocardial infarction Heart 95 1844-50

[8] Bax J(2006)Association between hospital process performance and outcomes among patients with acute coronary syndromes JAMA 295 1912-20

[9] Betriu A(2011)Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction JAMA 305 1677-84

[10] Hamm CW(2014)Monitoring guideline adherence in the management of acute coronary syndrome in hospitals: design of a multicentre study Neth Heart J 22 346-53